Pentacycloundecane-diol-Based HIV-1 Protease Inhibitors: Biological Screening, 2D NMR, and Molecular Simulation Studies-Reference-Cited by-同舟云学术

Pentacycloundecane-diol-Based HIV-1 Protease Inhibitors: Biological Screening, 2D NMR, and Molecular Simulation Studies

Published:2012-04-27 Issue:6 Volume:7 Page:1009-1019
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Honarparvar Bahareh,Makatini Maya M.,Pawar Sachin A.,Petzold Katja,Soliman Mahmoud E. S.,Arvidsson Per I.,Sayed Yasien,Govender Thavendran,Maguire Glenn E. M.,Kruger Hendrik G.

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cmdc.201100512/fullpdf

Reference78 articles.

1. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

2. Twenty years of therapy for HIV-1 infection

3. Rational Design of Peptide-Based HIV Proteinase Inhibitors

4. Hydroxyethylamine analogs of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease

5. Effect of hydroxyl group configuration in hydroxyethylamine dipeptide isosteres on HIV protease inhibition. Evidence for multiple binding modes

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Acrobatics in Polycyclic Frames: Synthesis of “Kurmanediol” via Post-synthetic Modification of Cage Molecules by Olefinic Metathesis;The Journal of Organic Chemistry;2023-07-28

2. Trends in NMR Structural Elucidation Of Polycyclic Cages, Namely: Adamantane, Pentacycloundecane and Trishomocubane;South African Journal of Chemistry;2021

3. Dehydroacetic Acid-Phenylhydrazone as a Potential Inhibitor for Wild-Type HIV-1 Protease: Structural, DFT, Molecular Dynamics, 3D QSAR and ADMET Characteristics;IRAN J CHEM CHEM ENG;2021

4. An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant;Journal of Computer-Aided Molecular Design;2018-02-03

5. Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach;Journal of Molecular Graphics and Modelling;2017-09